Click for best price
Triple X Syndrome Management Market Size, Share 2024
The global Triple X Syndrome Management market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Periodic Screening Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Triple X Syndrome Management include Centogene NV, Eurofins Discovery, Hoffmann-La Roche, Invitae Corporation, Illumina, Natera, PerkinElmer, Quest Diagnostics Incorporated and Eurofins LifeCodexx GmbH, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Triple X Syndrome Management, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Triple X Syndrome Management. This report contains market size and forecasts of Triple X Syndrome Management in global, including the following market information:
Global Triple X Syndrome Management Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We has surveyed the Triple X Syndrome Management companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Triple X Syndrome Management Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Triple X Syndrome Management Market Segment Percentages, by Type, 2023 (%)
Periodic Screening
Early Intervention Services
Speech Therapy
Occupational Therapy
Physical or Developmental Therapy
Global Triple X Syndrome Management Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Triple X Syndrome Management Market Segment Percentages, by Application, 2023 (%)
Hospitals
Specialty Clinics
Others
Global Triple X Syndrome Management Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Triple X Syndrome Management Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Triple X Syndrome Management revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Triple X Syndrome Management revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Centogene NV
Eurofins Discovery
Hoffmann-La Roche
Invitae Corporation
Illumina
Natera
PerkinElmer
Quest Diagnostics Incorporated
Eurofins LifeCodexx GmbH
Ravgen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Triple X Syndrome Management, market overview.
Chapter 2: Global Triple X Syndrome Management market size in revenue.
Chapter 3: Detailed analysis of Triple X Syndrome Management company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Triple X Syndrome Management in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Triple X Syndrome Management Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Triple X Syndrome Management Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Triple X Syndrome Management Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Triple X Syndrome Management Overall Market Size
2.1 Global Triple X Syndrome Management Market Size: 2023 VS 2030
2.2 Global Triple X Syndrome Management Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Triple X Syndrome Management Players in Global Market
3.2 Top Global Triple X Syndrome Management Companies Ranked by Revenue
3.3 Global Triple X Syndrome Management Revenue by Companies
3.4 Top 3 and Top 5 Triple X Syndrome Management Companies in Global Market, by Revenue in 2023
3.5 Global Companies Triple X Syndrome Management Product Type
3.6 Tier 1, Tier 2 and Tier 3 Triple X Syndrome Management Players in Global Market
3.6.1 List of Global Tier 1 Triple X Syndrome Management Companies
3.6.2 List of Global Tier 2 and Tier 3 Triple X Syndrome Management Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Triple X Syndrome Management Market Size Markets, 2023 & 2030
4.1.2 Periodic Screening
4.1.3 Early Intervention Services
4.1.4 Speech Therapy
4.1.5 Occupational Therapy
4.1.6 Physical or Developmental Therapy
4.2 By Type - Global Triple X Syndrome Management Revenue & Forecasts
4.2.1 By Type - Global Triple X Syndrome Management Revenue, 2019-2024
4.2.2 By Type - Global Triple X Syndrome Management Revenue, 2025-2030
4.2.3 By Type - Global Triple X Syndrome Management Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Triple X Syndrome Management Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Specialty Clinics
5.1.4 Others
5.2 By Application - Global Triple X Syndrome Management Revenue & Forecasts
5.2.1 By Application - Global Triple X Syndrome Management Revenue, 2019-2024
5.2.2 By Application - Global Triple X Syndrome Management Revenue, 2025-2030
5.2.3 By Application - Global Triple X Syndrome Management Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Triple X Syndrome Management Market Size, 2023 & 2030
6.2 By Region - Global Triple X Syndrome Management Revenue & Forecasts
6.2.1 By Region - Global Triple X Syndrome Management Revenue, 2019-2024
6.2.2 By Region - Global Triple X Syndrome Management Revenue, 2025-2030
6.2.3 By Region - Global Triple X Syndrome Management Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Triple X Syndrome Management Revenue, 2019-2030
6.3.2 US Triple X Syndrome Management Market Size, 2019-2030
6.3.3 Canada Triple X Syndrome Management Market Size, 2019-2030
6.3.4 Mexico Triple X Syndrome Management Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Triple X Syndrome Management Revenue, 2019-2030
6.4.2 Germany Triple X Syndrome Management Market Size, 2019-2030
6.4.3 France Triple X Syndrome Management Market Size, 2019-2030
6.4.4 U.K. Triple X Syndrome Management Market Size, 2019-2030
6.4.5 Italy Triple X Syndrome Management Market Size, 2019-2030
6.4.6 Russia Triple X Syndrome Management Market Size, 2019-2030
6.4.7 Nordic Countries Triple X Syndrome Management Market Size, 2019-2030
6.4.8 Benelux Triple X Syndrome Management Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Triple X Syndrome Management Revenue, 2019-2030
6.5.2 China Triple X Syndrome Management Market Size, 2019-2030
6.5.3 Japan Triple X Syndrome Management Market Size, 2019-2030
6.5.4 South Korea Triple X Syndrome Management Market Size, 2019-2030
6.5.5 Southeast Asia Triple X Syndrome Management Market Size, 2019-2030
6.5.6 India Triple X Syndrome Management Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Triple X Syndrome Management Revenue, 2019-2030
6.6.2 Brazil Triple X Syndrome Management Market Size, 2019-2030
6.6.3 Argentina Triple X Syndrome Management Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Triple X Syndrome Management Revenue, 2019-2030
6.7.2 Turkey Triple X Syndrome Management Market Size, 2019-2030
6.7.3 Israel Triple X Syndrome Management Market Size, 2019-2030
6.7.4 Saudi Arabia Triple X Syndrome Management Market Size, 2019-2030
6.7.5 UAE Triple X Syndrome Management Market Size, 2019-2030
7 Triple X Syndrome Management Companies Profiles
7.1 Centogene NV
7.1.1 Centogene NV Company Summary
7.1.2 Centogene NV Business Overview
7.1.3 Centogene NV Triple X Syndrome Management Major Product Offerings
7.1.4 Centogene NV Triple X Syndrome Management Revenue in Global Market (2019-2024)
7.1.5 Centogene NV Key News & Latest Developments
7.2 Eurofins Discovery
7.2.1 Eurofins Discovery Company Summary
7.2.2 Eurofins Discovery Business Overview
7.2.3 Eurofins Discovery Triple X Syndrome Management Major Product Offerings
7.2.4 Eurofins Discovery Triple X Syndrome Management Revenue in Global Market (2019-2024)
7.2.5 Eurofins Discovery Key News & Latest Developments
7.3 Hoffmann-La Roche
7.3.1 Hoffmann-La Roche Company Summary
7.3.2 Hoffmann-La Roche Business Overview
7.3.3 Hoffmann-La Roche Triple X Syndrome Management Major Product Offerings
7.3.4 Hoffmann-La Roche Triple X Syndrome Management Revenue in Global Market (2019-2024)
7.3.5 Hoffmann-La Roche Key News & Latest Developments
7.4 Invitae Corporation
7.4.1 Invitae Corporation Company Summary
7.4.2 Invitae Corporation Business Overview
7.4.3 Invitae Corporation Triple X Syndrome Management Major Product Offerings
7.4.4 Invitae Corporation Triple X Syndrome Management Revenue in Global Market (2019-2024)
7.4.5 Invitae Corporation Key News & Latest Developments
7.5 Illumina
7.5.1 Illumina Company Summary
7.5.2 Illumina Business Overview
7.5.3 Illumina Triple X Syndrome Management Major Product Offerings
7.5.4 Illumina Triple X Syndrome Management Revenue in Global Market (2019-2024)
7.5.5 Illumina Key News & Latest Developments
7.6 Natera
7.6.1 Natera Company Summary
7.6.2 Natera Business Overview
7.6.3 Natera Triple X Syndrome Management Major Product Offerings
7.6.4 Natera Triple X Syndrome Management Revenue in Global Market (2019-2024)
7.6.5 Natera Key News & Latest Developments
7.7 PerkinElmer
7.7.1 PerkinElmer Company Summary
7.7.2 PerkinElmer Business Overview
7.7.3 PerkinElmer Triple X Syndrome Management Major Product Offerings
7.7.4 PerkinElmer Triple X Syndrome Management Revenue in Global Market (2019-2024)
7.7.5 PerkinElmer Key News & Latest Developments
7.8 Quest Diagnostics Incorporated
7.8.1 Quest Diagnostics Incorporated Company Summary
7.8.2 Quest Diagnostics Incorporated Business Overview
7.8.3 Quest Diagnostics Incorporated Triple X Syndrome Management Major Product Offerings
7.8.4 Quest Diagnostics Incorporated Triple X Syndrome Management Revenue in Global Market (2019-2024)
7.8.5 Quest Diagnostics Incorporated Key News & Latest Developments
7.9 Eurofins LifeCodexx GmbH
7.9.1 Eurofins LifeCodexx GmbH Company Summary
7.9.2 Eurofins LifeCodexx GmbH Business Overview
7.9.3 Eurofins LifeCodexx GmbH Triple X Syndrome Management Major Product Offerings
7.9.4 Eurofins LifeCodexx GmbH Triple X Syndrome Management Revenue in Global Market (2019-2024)
7.9.5 Eurofins LifeCodexx GmbH Key News & Latest Developments
7.10 Ravgen
7.10.1 Ravgen Company Summary
7.10.2 Ravgen Business Overview
7.10.3 Ravgen Triple X Syndrome Management Major Product Offerings
7.10.4 Ravgen Triple X Syndrome Management Revenue in Global Market (2019-2024)
7.10.5 Ravgen Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Triple X Syndrome Management Market Opportunities & Trends in Global Market
Table 2. Triple X Syndrome Management Market Drivers in Global Market
Table 3. Triple X Syndrome Management Market Restraints in Global Market
Table 4. Key Players of Triple X Syndrome Management in Global Market
Table 5. Top Triple X Syndrome Management Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Triple X Syndrome Management Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Triple X Syndrome Management Revenue Share by Companies, 2019-2024
Table 8. Global Companies Triple X Syndrome Management Product Type
Table 9. List of Global Tier 1 Triple X Syndrome Management Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Triple X Syndrome Management Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Triple X Syndrome Management Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Triple X Syndrome Management Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Triple X Syndrome Management Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Triple X Syndrome Management Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Triple X Syndrome Management Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Triple X Syndrome Management Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Triple X Syndrome Management Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Triple X Syndrome Management Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Triple X Syndrome Management Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Triple X Syndrome Management Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Triple X Syndrome Management Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Triple X Syndrome Management Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Triple X Syndrome Management Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Triple X Syndrome Management Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Triple X Syndrome Management Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Triple X Syndrome Management Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Triple X Syndrome Management Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Triple X Syndrome Management Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Triple X Syndrome Management Revenue, (US$, Mn), 2025-2030
Table 30. Centogene NV Company Summary
Table 31. Centogene NV Triple X Syndrome Management Product Offerings
Table 32. Centogene NV Triple X Syndrome Management Revenue (US$, Mn) & (2019-2024)
Table 33. Centogene NV Key News & Latest Developments
Table 34. Eurofins Discovery Company Summary
Table 35. Eurofins Discovery Triple X Syndrome Management Product Offerings
Table 36. Eurofins Discovery Triple X Syndrome Management Revenue (US$, Mn) & (2019-2024)
Table 37. Eurofins Discovery Key News & Latest Developments
Table 38. Hoffmann-La Roche Company Summary
Table 39. Hoffmann-La Roche Triple X Syndrome Management Product Offerings
Table 40. Hoffmann-La Roche Triple X Syndrome Management Revenue (US$, Mn) & (2019-2024)
Table 41. Hoffmann-La Roche Key News & Latest Developments
Table 42. Invitae Corporation Company Summary
Table 43. Invitae Corporation Triple X Syndrome Management Product Offerings
Table 44. Invitae Corporation Triple X Syndrome Management Revenue (US$, Mn) & (2019-2024)
Table 45. Invitae Corporation Key News & Latest Developments
Table 46. Illumina Company Summary
Table 47. Illumina Triple X Syndrome Management Product Offerings
Table 48. Illumina Triple X Syndrome Management Revenue (US$, Mn) & (2019-2024)
Table 49. Illumina Key News & Latest Developments
Table 50. Natera Company Summary
Table 51. Natera Triple X Syndrome Management Product Offerings
Table 52. Natera Triple X Syndrome Management Revenue (US$, Mn) & (2019-2024)
Table 53. Natera Key News & Latest Developments
Table 54. PerkinElmer Company Summary
Table 55. PerkinElmer Triple X Syndrome Management Product Offerings
Table 56. PerkinElmer Triple X Syndrome Management Revenue (US$, Mn) & (2019-2024)
Table 57. PerkinElmer Key News & Latest Developments
Table 58. Quest Diagnostics Incorporated Company Summary
Table 59. Quest Diagnostics Incorporated Triple X Syndrome Management Product Offerings
Table 60. Quest Diagnostics Incorporated Triple X Syndrome Management Revenue (US$, Mn) & (2019-2024)
Table 61. Quest Diagnostics Incorporated Key News & Latest Developments
Table 62. Eurofins LifeCodexx GmbH Company Summary
Table 63. Eurofins LifeCodexx GmbH Triple X Syndrome Management Product Offerings
Table 64. Eurofins LifeCodexx GmbH Triple X Syndrome Management Revenue (US$, Mn) & (2019-2024)
Table 65. Eurofins LifeCodexx GmbH Key News & Latest Developments
Table 66. Ravgen Company Summary
Table 67. Ravgen Triple X Syndrome Management Product Offerings
Table 68. Ravgen Triple X Syndrome Management Revenue (US$, Mn) & (2019-2024)
Table 69. Ravgen Key News & Latest Developments
List of Figures
Figure 1. Triple X Syndrome Management Segment by Type in 2023
Figure 2. Triple X Syndrome Management Segment by Application in 2023
Figure 3. Global Triple X Syndrome Management Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Triple X Syndrome Management Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Triple X Syndrome Management Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Triple X Syndrome Management Revenue in 2023
Figure 8. By Type - Global Triple X Syndrome Management Revenue Market Share, 2019-2030
Figure 9. By Application - Global Triple X Syndrome Management Revenue Market Share, 2019-2030
Figure 10. By Type - Global Triple X Syndrome Management Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Triple X Syndrome Management Revenue Market Share, 2019-2030
Figure 12. By Application - Global Triple X Syndrome Management Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Triple X Syndrome Management Revenue Market Share, 2019-2030
Figure 14. By Region - Global Triple X Syndrome Management Revenue Market Share, 2019-2030
Figure 15. By Country - North America Triple X Syndrome Management Revenue Market Share, 2019-2030
Figure 16. US Triple X Syndrome Management Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Triple X Syndrome Management Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Triple X Syndrome Management Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Triple X Syndrome Management Revenue Market Share, 2019-2030
Figure 20. Germany Triple X Syndrome Management Revenue, (US$, Mn), 2019-2030
Figure 21. France Triple X Syndrome Management Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Triple X Syndrome Management Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Triple X Syndrome Management Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Triple X Syndrome Management Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Triple X Syndrome Management Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Triple X Syndrome Management Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Triple X Syndrome Management Revenue Market Share, 2019-2030
Figure 28. China Triple X Syndrome Management Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Triple X Syndrome Management Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Triple X Syndrome Management Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Triple X Syndrome Management Revenue, (US$, Mn), 2019-2030
Figure 32. India Triple X Syndrome Management Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Triple X Syndrome Management Revenue Market Share, 2019-2030
Figure 34. Brazil Triple X Syndrome Management Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Triple X Syndrome Management Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Triple X Syndrome Management Revenue Market Share, 2019-2030
Figure 37. Turkey Triple X Syndrome Management Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Triple X Syndrome Management Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Triple X Syndrome Management Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Triple X Syndrome Management Revenue, (US$, Mn), 2019-2030
Figure 41. Centogene NV Triple X Syndrome Management Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Eurofins Discovery Triple X Syndrome Management Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Hoffmann-La Roche Triple X Syndrome Management Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Invitae Corporation Triple X Syndrome Management Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Illumina Triple X Syndrome Management Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Natera Triple X Syndrome Management Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. PerkinElmer Triple X Syndrome Management Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Quest Diagnostics Incorporated Triple X Syndrome Management Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Eurofins LifeCodexx GmbH Triple X Syndrome Management Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Ravgen Triple X Syndrome Management Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
